Figure 1
Figure 1. STAT5 mediates CD103+ DC development and pDC inhibition. Hematopoietic-Stat5Δ/Δ and Stat5+/+ animals were treated by HGT with GM-CSF–encoding plasmid (5 μg) or empty pORF vector, as indicated. The proportion and absolute number of specific DC subsets in BM, spleen, and liver were determined after 7 days by flow cytometry (A) and enumeration (B). DC populations were defined by the following criteria: PDCs, CD11c+ CD11b- B220+; CD8α+ DCs, CD11c+ B220- CD8α+; CD4+ DCs, CD11c+ B220- CD4+; CD4- CD8α- DCs, CD11c+ B220- CD4- CD8α-; CD103+ DCs, CD11c+ CD45+ B220- MHC II+ CD103+. (A) Results indicate the percentage of each DC subset within the total BM, spleen, or liver population and represent data from 3 independent experiments. (B) Results indicate absolute numbers of each DC subset within BM (2 femurs, 2 tibiae), spleen, or liver. n = 3-6 mice/group. Error bars represent SEM of average values. P values of indicated comparisons are shown.

STAT5 mediates CD103+ DC development and pDC inhibition. Hematopoietic-Stat5Δ/Δ and Stat5+/+ animals were treated by HGT with GM-CSF–encoding plasmid (5 μg) or empty pORF vector, as indicated. The proportion and absolute number of specific DC subsets in BM, spleen, and liver were determined after 7 days by flow cytometry (A) and enumeration (B). DC populations were defined by the following criteria: PDCs, CD11c+ CD11b- B220+; CD8α+ DCs, CD11c+ B220- CD8α+; CD4+ DCs, CD11c+ B220- CD4+; CD4- CD8α- DCs, CD11c+ B220- CD4- CD8α-; CD103+ DCs, CD11c+ CD45+ B220- MHC II+ CD103+. (A) Results indicate the percentage of each DC subset within the total BM, spleen, or liver population and represent data from 3 independent experiments. (B) Results indicate absolute numbers of each DC subset within BM (2 femurs, 2 tibiae), spleen, or liver. n = 3-6 mice/group. Error bars represent SEM of average values. P values of indicated comparisons are shown.

Close Modal

or Create an Account

Close Modal
Close Modal